Evidence map›Paper›PMID 30826177›Full record

ArticleJournal of autoimmunity2019

Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis.

Maxwell J Heinrich, Caroline A Purcell, Andrea J Pruijssers, Yang Zhao, Charles F Spurlock, Subramaniam Sriram, Kristen M Ogden, Terence S Dermody, Matthew B Scholz, Philip S Crooke and 2 more

Abstract read
In one paragraph

Article in Journal of autoimmunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Zfp697 is an RNA-binding protein that regulates skeletal muscle inflammation and remodeling.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Science advances · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maxwell J HeinrichDepartments of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Caroline A PurcellDepartments of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Andrea J PruijssersDepartments of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Yang ZhaoDepartments of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Charles F SpurlockDepartments of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Subramaniam SriramDepartments of Neurology, Vanderbilt University Medical Center, Nashville, TN, 37212, USA.
Kristen M OgdenDepartments of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Terence S DermodyDepartments of Pediatrics and of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Matthew B ScholzVanderbilt Technologies for Advanced Genomics, Vanderbilt University Medical Center, Nashville, TN, 37212, USA.
Philip S CrookeDepartment of Mathematics, Vanderbilt University, Nashville, TN, 37212, USA.
John KarijolichDepartments of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37212, USA.
Thomas M AuneDepartments of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212, USA; Departments of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37212, USA. Electronic address: tom.aune@vanderbilt.edu.

Funding

IFN GAMMA GENE REGULATION IN T CELLS AND NK CELLSR01AI044924 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI AUNE, THOMAS M. · 2000 to 2019
$5.8M
MOLECULAR BASIS OF REOVIRUS PATHOGENESISR01AI038296 · NIAID · VANDERBILT UNIVERSITY · PI DERMODY, TERENCE S. · 1996 to 2019
$3.3M
Long non-coding RNA signatures to classify multiple sclerosisR44AI124766 · NIAID · IQUITY LABS, INC · PI AUNE, THOMAS M., SPURLOCK, CHARLES FLOYD · 2017 to 2018
$1.3M
Alu RNAs and double-stranded RNA sensorsR21AI144193 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI AUNE, THOMAS M. · 2019 to 2020
$468k
LncRNAs tether transcription factors to enable locus-specific regulation and sustain memory T cell phenotypeR21AI128281 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI AUNE, THOMAS M. · 2017 to 2018
$435k
NIAID NIH HHS R01 AI038296NIAID NIH HHS R01 AI044924NIAID NIH HHS R21 AI128281NIAID NIH HHS R21 AI144193NIAID NIH HHS R44 AI124766
6 · The paper itself

Abstract

Various sensors that detect double-stranded RNA, presumably of viral origin, exist in eukaryotic cells and induce IFN-responses. Ongoing IFN-responses have also been documented in a variety of human autoimmune diseases including relapsing-remitting multiple sclerosis (RRMS) but their origins remain obscure. We find increased IFN-responses in leukocytes in relapsing-remitting multiple sclerosis at distinct stages of disease. Moreover, endogenous RNAs isolated from blood cells of these same patients recapitulate this IFN-response if transfected into naïve cells. These endogenous RNAs are double-stranded RNAs, contain Alu and Line elements and are transcribed from leukocyte transcriptional enhancers. Thus, transcribed endogenous retrotransposon elements can co-opt pattern recognition sensors to induce IFN-responses in RRMS.

Indexed as

AdultAgedAlu ElementsFemaleHumansInterferonsLong Interspersed Nucleotide ElementsMaleMiddle AgedMultiple SclerosisRNA, Double-StrandedInterferonsRNA, Double-StrandedAlu retrotransposonDouble stranded RNA sensorInterferonsRelapsing remitting multiple sclerosis

Identifiers

PMID30826177
PMCPMC6513682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.